Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis-reply to Pazianas and Abrahamsen

Osteoporos Int. 2014 Nov;25(11):2671-2. doi: 10.1007/s00198-014-2789-z. Epub 2014 Jul 18.

Authors

M Tadrous¹, M M Mamdani, D N Juurlink, M D Krahn, L E Lévesque, S M Cadarette

Affiliation

¹ Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, M5S 3M2, Canada, mina.tadrous@utoronto.ca.

PMID: 25035138
DOI: 10.1007/s00198-014-2789-z

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Density Conservation Agents / adverse effects*
Diphosphonates / adverse effects*
Gastrointestinal Diseases / chemically induced*
Humans
Osteoporosis / drug therapy*

Substances

Bone Density Conservation Agents
Diphosphonates